Cases & Deals

  • Home
  • Practices
  • Celgene defends patents covering lenalidomide and apremilast before European Patent Office

Share

Celgene defends patents covering lenalidomide and apremilast before European Patent Office

June 2010

Clients Celgene Corporation

Jones Day represents Celgene Corporation in defense of patents covering lenalidomide and apremilast against oppositions brought before the European Patent Office by generic pharmaceutical companies.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.